| Literature DB >> 35953961 |
Carlos Wyson Tawanda Nantapo1,2, Upenyu Marume1,2.
Abstract
Myrothamnus flabellifolius (Welw.) is used in African traditional medicine for the treatment of depression and mental disorder, asthma, infectious diseases, respiratory, inflammation, epilepsy, heart, wound, backaches, diabetes, kidney ailments, hypertension, hemorrhoids, gingivitis, shingles, stroke, and skins conditions. The effectiveness of M. flabellifolius is due to the presence of several secondary metabolites that have demonstrated efficacy in other cell and animal models. These metabolites are key in cell regulation and function and have potential use in animal production due to antimicrobial and antioxidant properties, for an improvement in growth performance, feed quality and palatability, gut microbial environment, function, and animal health. The purpose of this review is to provide a detailed account on the potential use of M. flabellifolius in animal nutrition. Limitations towards the use of this plant in animal nutrition, including toxicity, economic, and financial issues are discussed. Finally, novel strategies and technologies, e.g., microencapsulation, microbial fermentation, and essential oil extraction, used to unlock and improve nutrient bioaccessibility and bioavailability are clearly discussed towards the potential use of M. flabellifolius as a phytogenic additive in animal diets.Entities:
Keywords: antimicrobial; antioxidants; bioaccessibility; bioavailability; essential oil; gut function; microencapsulation; phytogenic additive
Year: 2022 PMID: 35953961 PMCID: PMC9367323 DOI: 10.3390/ani12151973
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Phytochemicals present in Myrothamnus flabellifolius and potential benefits.
| Quantity | Potential Mode of Action | Reference | |
|---|---|---|---|
| Nutrient | |||
| Trehalose | 34.7 ± 7.2 mgg−1 | proteins and lipid stability | [ |
| Raffinose | 2.49 g/100 g | osmotic stress protection | [ |
| Gallic acid | 26.62% | Anti-obesity | [ |
| Ferulic acid | 15.23% | Antiinflammation | [ |
| Stachyose | 2.18 g/100 g | osmotic stress protection | [ |
| Sucrose | 56.5 ± 6.6 mgg−1 | [ | |
| Phytochemical | |||
| Carvacrol | - | Antibacterial, antioxidant | [ |
| 3,4,5 tri-O-galloylquicic acid | 0.73, 0.32, and 0.0029 g/100 g | Membrane protectant, | [ |
| Galloylquinic acid | - | Antioxidant | [ |
| Arbutin | - | Melanogenesis inhibitor | [ |
| Ellagic acid | - | Antioxidant | [ |
| Gallocatechin | 1.43 ± 0.03 mg/g | Chemoprotective, antioxidant, antibacterial | [ |
| Trans-pinocarveol | 19.57% | Antimicrobial | [ |
| Quercetin glucoside | 3 mg AWEw | Antioxidant | [ |
| Pinocarvone | 11.13% | Antimicrobial | [ |
Figure 1Mode of action based on secondary metabolites present in M. flabellifolius. The relationship between antioxidant, antimicrobial, immunostimulant, and gut health improvement properties of M. flabellifolius and how they affect growth performance, gut microflora, gut function, and meat quality.